{"id":934,"date":"2020-05-21T16:31:16","date_gmt":"2020-05-21T14:31:16","guid":{"rendered":"https:\/\/catalogue.acrosslimits.com\/?post_type=prof&p=934"},"modified":"2021-10-27T17:39:47","modified_gmt":"2021-10-27T15:39:47","slug":"cloud-htmd","status":"publish","type":"prof","link":"https:\/\/hcloud.acrosslimits.com\/?prof=cloud-htmd","title":{"rendered":"Cloud-HTMD"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","prof_acronym":"Cloud-HTMD","prof_full_name":"A CLOUD APPLICATION PLATFORM FOR RATIONAL DRUG DISCOVERY USING HIGH THROUGHPUT MOLECULAR DYNAMICS","prof_url":"https:\/\/cordis.europa.eu\/project\/rcn\/208510\/factsheet\/en ","prof_contact_name":"","prof_contact_organisation":"ACELLERA LABS SL","prof_contact_email":"","prof_contact_website":"","prof_strategic_goals":"","prof_solutions_developed":"Acellera is at the forefront in the development of Molecular Dynamics (MD) applications for drug discovery, and is committed to developing next generation tools that facilitate adoption of this technology by a wider segment of the drug discovery community.","prof_nice_description":"Acellera is at the forefront in the development of Molecular Dynamics (MD) applications for drug discovery, and is committed to developing next generation tools that facilitate adoption of this technology by a wider segment of the drug discovery community.","prof_project_type":[{"term_id":7,"name":"Private Initiative","slug":"private-sector","description":"","taxonomy":"prof_type","parent":[],"term_taxonomy_id":7,"term_group":0,"count":1,"id":7}],"prof_industry":[{"term_id":38,"name":"Health","slug":"health","description":"","taxonomy":"industries","parent":[],"term_taxonomy_id":38,"term_group":0,"count":0,"id":38}],"prof_start_date":"2017-09-01","prof_end_date":"2018-08-31","prof_project_focus":[{"term_id":14,"name":"Enabler","slug":"enabler","description":"This includes design and development of a technology that enables the operation of the cloud solution, such as a piece of hardware or software","taxonomy":"project_focus","parent":[],"term_taxonomy_id":14,"term_group":0,"count":0,"id":14}],"prof_geo_scope":false,"prof_geo_name_area":"","prof_hcloud_keywords":[{"term_id":130,"name":"Cloud","slug":"cloud","description":"","taxonomy":"h-cloud_keyword","parent":[],"term_taxonomy_id":130,"term_group":0,"count":0,"id":130}],"prof_cloud_delivery":[{"term_id":23,"name":"PaaS","slug":"paas","description":"","taxonomy":"cloud_delivery_model","parent":[],"term_taxonomy_id":23,"term_group":0,"count":0,"id":23},{"term_id":24,"name":"SaaS","slug":"saas","description":"","taxonomy":"cloud_delivery_model","parent":[],"term_taxonomy_id":24,"term_group":0,"count":0,"id":24}],"prof_cloud_deployment":false,"prof_life-cycle":[{"term_id":32,"name":"Operational Deployment","slug":"operational-deployment","description":"","taxonomy":"project_life-cycle_stage","parent":[],"term_taxonomy_id":32,"term_group":0,"count":0,"id":32},{"term_id":30,"name":"Research and Innovation","slug":"research-and-innovation","description":"","taxonomy":"project_life-cycle_stage","parent":[],"term_taxonomy_id":30,"term_group":0,"count":0,"id":30}],"prof_specific_domain":[{"term_id":48,"name":"Small and Medium Enterprises (SMEs)","slug":"small-and-medium-enterprises-smes","description":"","taxonomy":"specific_domain","parent":[],"term_taxonomy_id":48,"term_group":0,"count":0,"id":48}],"prof_technology":false,"prof_governance_model":"Acellera\u2019s strategy is to develop a powerful cloud-computing platform to widen access to high-throughput molecular dynamics simulations SaaS solution (Software as a Service). The aim is to accelerate market uptake of computational drug discovery and drive down the cost of development in the pharmaceutical industry.","prof_operating_model":[{"term_id":58,"name":"Centralised","slug":"centralised","description":"","taxonomy":"operating_model","parent":[],"term_taxonomy_id":58,"term_group":0,"count":0,"id":58}],"prof_ownership":[{"term_id":61,"name":"Centralised","slug":"centralised","description":"","taxonomy":"ownerships","parent":[],"term_taxonomy_id":61,"term_group":0,"count":0,"id":61}],"prof_eu_contribution":"75000.00","prof_overall_budget":"75000.00","prof_tipology":"","prof_distribution_revenues":"","prof_stake_public_sector":false,"prof_stake_academia_research":false,"prof_stake_industry":[{"ID":935,"post_title":"ACELLERA LABS SL (Spain)","post_content":"","post_excerpt":"","post_author":"1","post_date":"2020-05-21 16:27:33","post_date_gmt":"2020-05-21 14:27:33","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"acellera-labs-sl-spain","to_ping":"","pinged":"","post_modified":"2020-05-21 16:27:33","post_modified_gmt":"2020-05-21 14:27:33","post_content_filtered":"","post_parent":[],"guid":"https:\/\/catalogue.acrosslimits.com\/?post_type=organisation&p=935","menu_order":0,"post_type":"organisation","post_mime_type":"","comment_count":"0","comments":false,"id":935}],"prof_stake_community":false,"prof_stake_other":false,"prof_target_users":[{"ID":434,"post_title":"Industry","post_content":"","post_excerpt":"","post_author":"1","post_date":"2020-05-19 09:10:08","post_date_gmt":"2020-05-19 07:10:08","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"industry","to_ping":"","pinged":"","post_modified":"2020-05-19 09:10:08","post_modified_gmt":"2020-05-19 07:10:08","post_content_filtered":"","post_parent":[],"guid":"https:\/\/catalogue.acrosslimits.com\/?post_type=target_user&p=434","menu_order":0,"post_type":"target_user","post_mime_type":"","comment_count":"0","comments":false,"id":434}],"prof_number_of_users":[],"prof_growth_rate":[],"prof_revenues":"0.00","prof_revenues_increase":[],"prof_customer_satisfaction":"","prof_sme_impact":[{"term_id":66,"name":"High","slug":"high","description":"","taxonomy":"sme_impact","parent":[],"term_taxonomy_id":66,"term_group":0,"count":0,"id":66}],"prof_description_of_socio-economic_impact":"The development of the new tools will allow answering the unmet need to enable any small, medium company to perform similar in-silico protocols of top-pharmaceutical companies for accelerating their discovery pipelines.","prof_lessons_learned":"","prof_good_practice":false,"prof_good_practice_reason":"","prof_business_success":"","prof_technology_innovation":"","prof_data_governance":"","prof_environment_and_sustainability":"","prof_governance_and_organizational_structure":"","_links":{"self":[{"href":"https:\/\/hcloud.acrosslimits.com\/index.php?rest_route=\/wp\/v2\/prof\/934"}],"collection":[{"href":"https:\/\/hcloud.acrosslimits.com\/index.php?rest_route=\/wp\/v2\/prof"}],"about":[{"href":"https:\/\/hcloud.acrosslimits.com\/index.php?rest_route=\/wp\/v2\/types\/prof"}],"wp:attachment":[{"href":"https:\/\/hcloud.acrosslimits.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}